Medacta Group SA (MEDGF) Q4 2025 Earnings Call Transcript
Medacta Group SA (MEDGF) Q4 2025 Sales/Trading Call Transcript
| Health Care Equipment & Supplies Industry | Healthcare Sector | Francesco Siccardi CEO | OTC PINK Exchange | CH0468525222 ISIN |
| CH Country | 1,907 Employees | 7 May 2026 Last Dividend | - Last Split | - IPO Date |
Medacta Group SA is a globally recognized company specializing in the development, manufacture, and distribution of orthopedic and neurosurgical medical devices. With a network spreading across Europe, North America, the Asia-Pacific, and beyond, Medacta has cemented its position as a leading provider in the medical device industry. Since its inception in 1958, Medacta has been committed to improving the standard of care for patients around the world. Headquartered in Castel San Pietro, Switzerland, the company continues to innovate and expand its reach, ensuring that healthcare providers have access to the latest and most advanced medical technologies.
Medacta Group SA offers a comprehensive range of products and services designed to support healthcare professionals in orthopedic and neurosurgical procedures. These include: